Animal models for COVID-19 C Muñoz-Fontela, WE Dowling, SGP Funnell, PS Gsell, AX Riveros-Balta, ... Nature 586 (7830), 509-515, 2020 | 810 | 2020 |
Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model L Oestereich, A Lüdtke, S Wurr, T Rieger, C Muñoz-Fontela, S Günther Antiviral research 105, 17-21, 2014 | 629 | 2014 |
SARS-CoV-2 variants and vaccines PR Krause, TR Fleming, IM Longini, R Peto, S Briand, DL Heymann, ... New England Journal of Medicine 385 (2), 179-186, 2021 | 395 | 2021 |
Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa MW Carroll, DA Matthews, JA Hiscox, MJ Elmore, G Pollakis, A Rambaut, ... Nature 524 (7563), 97-101, 2015 | 366 | 2015 |
Emerging roles of p53 and other tumour-suppressor genes in immune regulation C Muñoz-Fontela, A Mandinova, SA Aaronson, SW Lee Nature Reviews Immunology 16 (12), 741-750, 2016 | 330 | 2016 |
Zika virus infections imported to Italy: clinical, immunological and virological findings, and public health implications L Zammarchi, G Stella, A Mantella, D Bartolozzi, D Tappe, S Günther, ... Journal of Clinical Virology 63, 32-35, 2015 | 282 | 2015 |
Transcriptional role of p53 in interferon-mediated antiviral immunity C Muñoz-Fontela, S Macip, L Martínez-Sobrido, L Brown, J Ashour, ... The Journal of experimental medicine 205 (8), 1929-1938, 2008 | 261 | 2008 |
Cytokine kinetics of Zika virus-infected patients from acute to reconvalescent phase D Tappe, JV Pérez-Girón, L Zammarchi, J Rissland, DF Ferreira, ... Medical microbiology and immunology 205, 269-273, 2016 | 223 | 2016 |
Unique human immune signature of Ebola virus disease in Guinea P Ruibal, L Oestereich, A Lüdtke, B Becker-Ziaja, DM Wozniak, R Kerber, ... Nature 533 (7601), 100-104, 2016 | 181 | 2016 |
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation A Rialdi, L Campisi, N Zhao, AC Lagda, C Pietzsch, JSY Ho, ... Science 352 (6289), aad7993, 2016 | 157 | 2016 |
Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus X Liu, E Speranza, C Muñoz-Fontela, S Haldenby, NY Rickett, ... Genome biology 18, 1-17, 2017 | 148 | 2017 |
Efficacy of favipiravir alone and in combination with ribavirin in a lethal, immunocompetent mouse model of Lassa fever L Oestereich, T Rieger, A Lüdtke, P Ruibal, S Wurr, E Pallasch, S Bockholt, ... The Journal of infectious diseases 213 (6), 934-938, 2016 | 126 | 2016 |
Dual role of p53 in innate antiviral immunity C Rivas, SA Aaronson, C Munoz-Fontela Viruses 2 (1), 298-313, 2010 | 123 | 2010 |
p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus C Muñoz-Fontela, M Pazos, I Delgado, W Murk, SK Mungamuri, SW Lee, ... The Journal of Immunology 187 (12), 6428-6436, 2011 | 101 | 2011 |
Cell senescence is an antiviral defense mechanism M Baz-Martínez, S Da Silva-Álvarez, E Rodríguez, J Guerra, A El Motiam, ... Scientific reports 6 (1), 37007, 2016 | 99 | 2016 |
Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene L Marcos-Villar, F Lopitz-Otsoa, P Gallego, C Munoz-Fontela, ... Journal of virology 83 (17), 8849-8858, 2009 | 93 | 2009 |
Resistance to viral infection of super p53 mice C Munoz-Fontela, M Angel Garcia, I Garcia-Cao, M Collado, J Arroyo, ... Oncogene 24 (18), 3059-3062, 2005 | 93 | 2005 |
Outbreaks in a rapidly changing Central Africa—lessons from Ebola VJ Munster, DG Bausch, E De Wit, R Fischer, G Kobinger, ... New England Journal of Medicine 379 (13), 1198-1201, 2018 | 84 | 2018 |
Estrogen mediates innate and adaptive immune alterations to influenza infection in pregnant mice MA Pazos, TA Kraus, C Munoz-Fontela, TM Moran PloS one 7 (7), e40502, 2012 | 76 | 2012 |
Advances and gaps in SARS-CoV-2 infection models C Muñoz-Fontela, L Widerspick, RA Albrecht, M Beer, MW Carroll, ... PLoS pathogens 18 (1), e1010161, 2022 | 67 | 2022 |